Oppenheimer initiated coverage of ARS Pharmaceuticals (SPRY) with an Outperform rating and $40 price target As the first and only approved ...
Parkinson’s Disease Companies are UCB Biopharma SRL, Novartis, Annovis Bio, Supernus Pharmaceuticals, Inc., Britannia Pharmaceutical, Pharma Two B, Mitsubishi Tanabe Pharma, NeuroDerm ...
Copyright © 2025 MarketWatch, Inc. All rights reserved.
Rocket Pharmaceuticals (RCKT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo The U.S. Food and Drug Administration ...
Type a few symbols and Take a Trial. The signals for these will appear immediately on your My Stocks Page; add more too.
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Infinity Pharmaceuticals Inc. 0.00% $90.76 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback